SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : RMGG

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Stock who wrote (944)6/8/1999 7:53:00 PM
From: Bencio Dad  Read Replies (1) of 1170
 
To those who still follow this stock and have held on to their faint hopes, here's news. Not much, but better than zilch. (Note: It's supposed to be for release tomorrow, June 9, though it incorrectly says May 9 on the release).

*********************************************************************

NEWS RELEASE

May 9, 1999

Rocky Mountain Ginseng, Inc. (OTCBB: RMGG) is pleased to announce that the first stage of construction to the new facility in Fuzhou was completed ahead of schedule and under budget. Administration staff are now working out of the new facility while construction of the GMP manufacturing plant commences in the new building.

Manufacturing of the traditional Fuzhou Fujian Drugs products will continue to be produced in the existing factory until the new facility is completed at which time all manufacturing will be done in the new plant.

Equipment for the production of Heavenly Slices and Ginseng Honey was
purchased in North America and shipped by container to Fuzhou on June 4, 1999. The Company projects that the new manufacturing facility will be complete and fully operational by August 31, 1999.

Recent meetings held in Fuzhou with representatives from RMGG along with a European pharmaceutical company and officials from the Chinese Drug Bureau resulted in a mutual understanding of the proper procedures required for RMGG to market Western pharmaceutical products in China. RMGG and the European company are presently working on a marketing agreement to distribute approved pharmaceutical products and also determine the feasibility of manufacturing additional products in China in the future.

For further information and updates, please send us your e-mail address to rlbell@direct.ca or visit our website at www.direct.ca/ginseng.

The statements made in this news release may contain certain forward
looking statements. Actual events or results may differ from the Company's expectations. Certain risk factors may also affect the results achieved by the Company.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext